论文信息 - Efficacy and safety of continuous daily sunitinib dosing in previously treated advanced non-small cell lung cancer (NSCLC): Results from a phase II study - 字舞流文

Efficacy and safety of continuous daily sunitinib dosing in previously treated advanced non-small cell lung cancer (NSCLC): Results from a phase II study

M. Socinski | R. Govindan | L. Tye | S. Novello | R. Rosell | J. Atkins | J. Brahmer | R. Chao | C. Belani | H. Gillenwater